CEACAM5 and neoplasm: In our center, patients' clinical characteristics, gadoxetic acid-enhanced MRI and contrast-enhanced ultrasonography, tumor markers (CEA and CA19-9), and ctDNA testing results are combined to comprehensively evaluate and identify patients who have a possibility of achieving pCR.